CN1090954C - Gastritis capsule - Google Patents

Gastritis capsule Download PDF

Info

Publication number
CN1090954C
CN1090954C CN99104281A CN99104281A CN1090954C CN 1090954 C CN1090954 C CN 1090954C CN 99104281 A CN99104281 A CN 99104281A CN 99104281 A CN99104281 A CN 99104281A CN 1090954 C CN1090954 C CN 1090954C
Authority
CN
China
Prior art keywords
grams
radix
rhizoma
root
gastritis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN99104281A
Other languages
Chinese (zh)
Other versions
CN1273845A (en
Inventor
马斌
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN99104281A priority Critical patent/CN1090954C/en
Publication of CN1273845A publication Critical patent/CN1273845A/en
Application granted granted Critical
Publication of CN1090954C publication Critical patent/CN1090954C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention discloses a Chinese patent medicine for treating gastritis, which is prepared from 4.5 wt% to 5.5 wt% of astragalus root, 3.5 wt% to 4.5 wt% of pilose asiabell root, 3.5 wt% to 4.5 wt% of tuckahoe, 6.5 wt% to 7.5 wt% of slender dutchmanspipe root, 0.8 wt% to 1.2 wt% of coptis, 0.6 wt% to 1 wt% of evodia, 4.5 wt% to 5.5 wt% of Chinese pulsatilla root, 4.5 wt% to 5.5 wt% of fructus toosendan, 3.5 wt% to 4.5 wt% of rhizoma corydalis, 2.5 wt% to 3.5 wt% of langpian, 3.5 wt% to 4.5 wt% of white atractylodes rhizome, 3.5 wt% to 4.5 wt%of immature orange fruit, 2.5 wt% to 3.5 wt% of chicken gizzard-membrane, 2.5 wt% to 3.5 wt% of rhizoma zedoariae, 1.3 wt% to 1.7 wt% of olibanum, 2.5 wt% to 3.5 wt% of raw sanguisorba, 3.5 wt% to 4.5 wt% of bletilla striata, 2.5 wt% to 3.5 wt% of gallnut, 3.5 wt% to 4.5 wt% of cuttlefish bone, 1.5 wt% to 2.5 wt% of cassia bark , 1.3 wt% to 1.7 wt% of liquorice, etc. The Chinese patent medicine has conspicuous effects of eliminating, expelling and killing helicobacter pylori, promoting the rehabilitation of gastric pathologic change and promoting the restoration and the concrescence of gastric mucosa.

Description

Gastritis capsule
The invention belongs to a kind of Chinese patent medicine for the treatment of gastritis.
Studies show that through the medical expert: helicobacter pylori is to cause the important pathogenic pathogen of various disease of stomach (chronic active gastritis, gastric ulcer, duodenal ulcer, gastric cancer etc.).Eliminating helicobacter pylori infections is a research topic of radical cure chronic active gastritis, although there is the multiple stomach new drug of controlling to come out, through clinical verification, effect is also not exclusively desirable.And helicobacter pylori infections acts on the skin of mucosa tissue, forms cytoclasis inflammation tissue, discharges the inflammatory mediator of brute force, produces a series of inflammatory pains, dyspepsia, symptom that power is not good enough.
The present invention's purpose is to provide a kind of new drug for the treatment of gastritis, and useful tachypnea is moving, the effect of detoxicating, killing bacteria, blood-activating analgetic, protection mucosa.
For reaching above-mentioned purpose, the technical scheme that the present invention takes is: the present invention, selectes following Chinese medicinal ingredients, and is equipped with rational proportion (weight ratio) through pharmacology analysis research and clinical trial according to the root of gastritis disease:
The Radix Astragali: Radix Codonopsis: Poria: Radix Aristolochiae: Rhizoma Coptidis: Fructus Evodiae: the Radix Pulsatillae: Fructus Toosendan, Rhizoma Corydalis: bulky: the Rhizoma Atractylodis Macrocephalae; Fructus Aurantii Immaturus: Endothelium corneum: Rhizoma Curcumae: Olibanum: Radix Sangusorbae: the Pseudobulbus Bletillae (Rhizoma Bletillae): Galla Chinensis: Endoconcha Sepiae: Cortex Cinnamomi: Radix Glycyrrhizae=4.5~5.5: 3.5~4.5: 3.5~4.5: 6.5~7.5: 0.8~1.2: 0.6~1: 4.5~5.5: 4.5~5.5: 3.5~4.5: 2.5~3.5: 3.5~4.5: 3.5~4.5: 2.5~3.5 :~2.5~3.5: 1.3~1.7: 2.5~3.5: 3.5~4.5: 2.5~3.5: 3.5~4.5: 1.5~2.5: 1.3~1.7.
Its best proportioning is: 5: 4: 4: 7: 1: 0.8: 5: 5: 4: 3: 4: 4: 3: 3: 1.5: 3: 4: 3: 4: 2: 1.5.
Pathological analysis and compatibility meaning: at present, comparatively general chronic active gastritis exists obstinate, the situation of empty condition under day, thereby causes gastric qi deficient, make helicobacter pylori infections become the stomach lining inflammation infringement to be on the rise thoroughly, formed just more empty and evil complex situations of more containing.Based on above-mentioned pathological change, in time adjust gastric qi, the strong moving function of priority restores taste has only gastric qi strong, and be expected the day after tomorrow, gastric qi weakness, the empty sick calamity of body.Selected the Radix Astragali, Radix Codonopsis, Poria, the Rhizoma Atractylodis Macrocephalae, Fructus Aurantii Immaturus etc. in the event side, training invigorating middle warmer gas is as a means of the change source; Next cooperates the detoxicating, killing bacteria medicine, selected Rhizoma Coptidis, Radix Aristolochiae, the Radix Pulsatillae, Fructus Toosendan, bulky etc., confirm according to another pharmacological research: the detoxicating, killing bacteria medicine has disease-resistant source action of microorganisms, can directly kill helicobacter pylori, promotes Gastric Diseases by Spraying to take a turn for the better and struvite change; The 3rd, blood circulation promoting and blood stasis dispelling, the protection mucosa, according to the fine sem observation of stomach, chronic gastritis has struvite ecchymosis and sheath sample hypertrophy in various degree, and mucosal erosion also has oozing of blood.Learn from clinical, give birth to slowly the gastritis sufferer again more see with scorching hot in the stomach, noisy twinge, feeling of fullness stop up, belch is done frequently, the sign of the dim ecchymosis of tongue, deep and stringy pulse and blood stasis network resistance such as puckery.Cooperate Rhizoma Corydalis, Olibanum, Rhizoma Curcumae with the disperse blood stasis and dredge collateral pain relieving for this reason.Assistant promotes the reparation and the healing of gastric mucosa with Radix Sangusorbae, Galla Chinensis, the Pseudobulbus Bletillae (Rhizoma Bletillae), Endoconcha Sepiae, and effect is remarkable.
Beneficial effect of the present invention is: can produce and remove the cytotoxin helicobacter pylori, make gastric epithelial cell cavity, necrosis occur, Peptic Ulcers becomes to correct, and stomach erosive inflammation is all disappeared, and the protection gastrointestinal mucosa heals the ulcer focus rapidly.Through clinical trial, total effective rate of the present invention reaches 98%, and cure rate is 92.6%.
Embodiment one
The Radix Astragali 50 gram, Radix Codonopsis 40 grams, Poria 40 grams, Radix Aristolochiae 70 grams, Rhizoma Coptidis 10 grams, Fructus Evodiae 8 grams, the Radix Pulsatillae 50 grams, Fructus Toosendan 50 grams, Rhizoma Corydalis 40 grams, bulky 30 gram, the Rhizoma Atractylodis Macrocephalae 40 grams, Fructus Aurantii Immaturus 40 grams, Endothelium corneum 30 grams, Rhizoma Curcumae 30 grams, Olibanum 15 grams, Radix Sangusorbae 30 grams, the Pseudobulbus Bletillae (Rhizoma Bletillae) 40 grams, Galla Chinensis 30 grams, Endoconcha Sepiae 40 grams, Cortex Cinnamomi 20 grams, Radix Glycyrrhizae 15 grams.
Embodiment two
The Radix Astragali 51 gram, Radix Codonopsis 42 grams, Poria 38 grams, Radix Aristolochiae 65 grams, Rhizoma Coptidis 11 grams, Fructus Evodiae 9 grams, the Radix Pulsatillae 54 grams, Fructus Toosendan 47 grams, Rhizoma Corydalis 39 grams, bulky 32 gram, the Rhizoma Atractylodis Macrocephalae 43 grams, Fructus Aurantii Immaturus 42 grams, Endothelium corneum 28 grams, Rhizoma Curcumae 31 grams, Olibanum 16 grams, Radix Sangusorbae 32 grams, the Pseudobulbus Bletillae (Rhizoma Bletillae) 42 grams, Galla Chinensis 31 grams, Endoconcha Sepiae 45 grams, Cortex Cinnamomi 18 grams, Radix Glycyrrhizae 14 grams.
Embodiment three
The Radix Astragali 49 gram, Radix Codonopsis 39 grams, Poria 42 grams, Radix Aristolochiae 75 grams, Rhizoma Coptidis 9 grams, Fructus Evodiae 7 grams, the Radix Pulsatillae 48 grams, Fructus Toosendan 53 grams, Rhizoma Corydalis 41 grams, bulky 31 gram, the Rhizoma Atractylodis Macrocephalae 38 grams, Fructus Aurantii Immaturus 39 grams, Endothelium corneum 32 grams, Rhizoma Curcumae 29 grams, Olibanum 14 grams, Radix Sangusorbae 28 grams, the Pseudobulbus Bletillae (Rhizoma Bletillae) 39 grams, Galla Chinensis 29 grams, Endoconcha Sepiae 38 grams, Cortex Cinnamomi 22 grams, Radix Glycyrrhizae 16 grams.
With embodiment one, embodiment two, embodiment three thing that makes up a prescription, in the capsule of 0.5 gram of packing into after the pulverizing.The patient obeys three every day, obeys 5 every day and gets final product.

Claims (1)

1. gastritis capsule, it is characterized in that it is made up of following components in weight percentage: the Radix Astragali, Radix Codonopsis, Poria, Radix Aristolochiae, Rhizoma Coptidis, Fructus Evodiae, the Radix Pulsatillae, Fructus Toosendan, Rhizoma Corydalis, bulky, the Rhizoma Atractylodis Macrocephalae, Fructus Aurantii Immaturus, Endothelium corneum, Rhizoma Curcumae, Olibanum, Radix Sangusorbae, the Pseudobulbus Bletillae (Rhizoma Bletillae), Galla Chinensis, Endoconcha Sepiae, Cortex Cinnamomi and Radix Glycyrrhizae, each set of dispense ratio is 4.5~5.5: 3.5~4.5: 3.5~4.5: 6.5~7.5: 0.8~1.2: 0.6~1: 4.5~5.5: 4.5~5.5: 3.5~4.5: 2.5~3.5: 3.5~4.5: 3.5~4.5: 2.5~3.5 :~2.5~3.5: 1.3~1.7: 2.5~3.5: 3.5~4.5: 2.5~3.5: 3.5~4.5: 1.5~2.5: 1.3~1.7.
CN99104281A 1999-05-13 1999-05-13 Gastritis capsule Expired - Fee Related CN1090954C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN99104281A CN1090954C (en) 1999-05-13 1999-05-13 Gastritis capsule

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN99104281A CN1090954C (en) 1999-05-13 1999-05-13 Gastritis capsule

Publications (2)

Publication Number Publication Date
CN1273845A CN1273845A (en) 2000-11-22
CN1090954C true CN1090954C (en) 2002-09-18

Family

ID=5271614

Family Applications (1)

Application Number Title Priority Date Filing Date
CN99104281A Expired - Fee Related CN1090954C (en) 1999-05-13 1999-05-13 Gastritis capsule

Country Status (1)

Country Link
CN (1) CN1090954C (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1301125C (en) * 2003-09-12 2007-02-21 贵州苗药雪胆胃肠丸科技中心 Medicine for treating gastrointestinal tract disease
CN1327883C (en) * 2005-04-04 2007-07-25 王双元 Traditional Chinese medicine for treating stomach disease
CN102671098B (en) * 2012-05-15 2014-01-08 宋协勘 Traditional Chinese medicine for treating peptic ulcer
CN102755601B (en) * 2012-08-08 2014-01-15 杨洪义 Traditional Chinese medicine for treating stomach illness and preparation method thereof
CN107536994A (en) * 2017-09-13 2018-01-05 徐秀环 Powder medicine for treating gastritis and gastric ulcer
CN107802810A (en) * 2017-11-17 2018-03-16 闫柏林 Composition for treating stomach trouble and preparation method thereof
CN107897452A (en) * 2017-12-29 2018-04-13 广东德海农业有限公司 A kind of lemon tea for promoting gastric mucosal
CN108324921B (en) * 2018-05-18 2021-02-19 宁波御坊堂生物科技有限公司 A pharmaceutical composition with cyst removing and gastric mucosa protecting effects, and its preparation method

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1075090A (en) * 1993-01-09 1993-08-11 朝阳市第二医院 Treatment chronic gastritis Chinese medicine stomachic tablet and preparation method thereof
CN1094959A (en) * 1993-05-13 1994-11-16 山东省医学科学院基础医学研究所 A kind of Chinese medicine for the treatment of gastropathy
CN1162479A (en) * 1997-05-08 1997-10-22 贾喜库 Powder for curing gastritis and preparation thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1075090A (en) * 1993-01-09 1993-08-11 朝阳市第二医院 Treatment chronic gastritis Chinese medicine stomachic tablet and preparation method thereof
CN1094959A (en) * 1993-05-13 1994-11-16 山东省医学科学院基础医学研究所 A kind of Chinese medicine for the treatment of gastropathy
CN1162479A (en) * 1997-05-08 1997-10-22 贾喜库 Powder for curing gastritis and preparation thereof

Also Published As

Publication number Publication date
CN1273845A (en) 2000-11-22

Similar Documents

Publication Publication Date Title
CN102139030B (en) Oral Chinese herbal preparation for treating gingivitis and preparation method thereof
CN102526616B (en) Chinese medicinal herb pills for treating cholecystitis and gallstone
CN102512630B (en) Traditional Chinese medicine composition for treating gallbladder calculus
CN1090954C (en) Gastritis capsule
CN105213941A (en) A kind of Chinese medicine composition being used for the treatment of infantile diarrhea and preparation method thereof
CN101347594A (en) Method for preparing Chinese medicine for treating kidney-yang deficiency type diarrhea
CN1069527C (en) Medicine for hyperosteogeny and wind-cold syndrome
CN1172690C (en) Chinese medicine powder for treating tetanic rachitis
CN101468194A (en) Medicine composition for treating colitis and method of making the same
CN103263601A (en) Chinese herbal preparation for accelerating fracture post-operation healing and preparation method of Chinese herbal preparation
CN102793904B (en) Preparation method for traditional Chinese medicine lotion for treatment of confusing-type closed fracture
CN1219525C (en) Chinese medicine for treating women's ovary cancer and uterine myoma
CN104258308A (en) Traditional Chinese medicine preparation for treating cholelithiasis
CN102451315A (en) Preparation method for traditional Chinese drug preparation for treating acute cholecystitis
CN102614350A (en) Chinese medicine for treating cervical spondylosis
CN103007238B (en) Traditional Chinese medicine composition for treating decubitus ulcers
CN105031267A (en) Prescription for treating periodontitis and preparation method
CN105943924A (en) Traditional Chinese medicine for treating gallbladder fire exuberance syndrome type multiple gall-stone
CN105561182A (en) Traditional Chinese medicinal preparation for treating renal calculus, and preparation method thereof
CN1966005A (en) Medicament for treating cervical spondylosis
CN105560893A (en) Traditional Chinese medicine composition for treating periodontitis
CN104491255A (en) Traditional Chinese medicine preparation for treating acute cholecystitis
CN105106692A (en) Traditional Chinese medicinal composition for gallstone postoperative recovery and preparation method of traditional Chinese medicinal composition
CN1099633A (en) Baicao antiphlogistic pill
CN1175852C (en) Medicine for treating hyperosteogeny

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee